Norvan Vartevan, DO
Pain Medicine · Paradise Valley, AZNPI 1093051674
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $476 of the $606 with a category attached, or 78.6%. 10 manufacturers reported payments, led by SPR Therapeutics, Inc at 28.9% of the total. 2025 is the largest year on record at $217, 2.6 times the $85 reported in 2021. That places this record below the midpoint for pain medicine clinicians in AZ, where the typical reported total is $3,853.
Across 19 payments — averaging $31.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SPR Therapeutics, Inc$175
- Curonix LLC$88
- Abbott$86
- Flower Orthopedics Coporation$66
- Stimwave Technologies Incorporated$62
- Hikma Pharmaceuticals USA$42
- plus $87 from 4 others
What the payments were for
- Travel & lodging$8815%
- Food & beverage$47679%
- Education$427%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SPR Therapeutics, Inc | 5 | $175 |
| Curonix LLC | 2 | $88 |
| Abbott | 4 | $86 |
| Flower Orthopedics Coporation | 1 | $66 |
| Stimwave Technologies Incorporated | 1 | $62 |
| Hikma Pharmaceuticals USA | 2 | $42 |
| Vertex | 1 | $24 |
| Almatica Pharma LLC | 1 | $22 |
| AbbVie | 1 | $21 |
| Boston Scientific | 1 | $21 |
How this compares
$606 in reported general payments places this provider in the 15th percentile of 180 pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 17 | $180 |
| Methylprednisolone | 13 | $103 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Paradise Valley
- Eric CornidezTucson$496K
- Tory McJunkinScottsdale$204K
- Minesh ZaveriPhoenix$187K
- Chad PletnickOro Valley$137K
- Tristan PicoChandler$121K
- Selaiman NooriLake Havasu City$104K
- Christine HaddadPhoenix$98K
- Samir PatelOro Valley$70K
- Vivek IyerScottsdale$70K
- Kirk BowdenMesa$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.